Method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides

US12281137B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12281137-B2
Application numberUS-202318112952-A
CountryUS
Kind codeB2
Filing dateFeb 22, 2023
Priority dateAug 8, 2013
Publication dateApr 22, 2025
Grant dateApr 22, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are analogs of unnatural nucleotides bearing predominantly hydrophobic nucleobase analogs that form unnatural base pairs during DNA polymerase-mediated replication of DNA or RNA polymerase-mediated transcription of RNA. In this manner, the unnatural nucleobases can be introduced in a site-specific way into oligonucleotides (single or double stranded DNA or RNA), where they can provide for site-specific cleavage, or can provide a reactive linker than can undergo functionalization with a cargo-bearing reagent by means of reaction with a primary amino group or by means of click chemistry with an alkyne group of the unnatural nucleobase linker.

First claim

Opening claim text (preview).

What is claimed is: 1. A nucleobase pair comprising a first nucleobase analog having the structure β9b, and a second nucleobase analog having any of the structures α15a or α15b: wherein each X is independently carbon or nitrogen, wherein each R 1 is independently hydrogen, alkyl group, a reactive linker comprising a reactive center a linker coupled to a cargo, wherein each R 2 is optional and when present is independently hydrogen, alkyl, alkenyl, alkynyl, methoxy, methanethiol, methaneseleno, halogen, cyano, azide, nitro group, a reactive linker comprising a reactive center, or a linker coupled to a cargo, wherein each Y is independently sulfur, oxygen, selenium, or a secondary amine, wherein each E is independently oxygen, sulfur or selenium, and the wavy line indicates a point of bonding to a ribosyl, deoxyribosyl, or dideoxyribosyl moiety or an analog thereof, wherein the ribosyl, deoxyribosyl, or dideoxyribosyl moiety, or analog thereof is in free form, is bound to a mono-phosphate, diphosphate, triphosphate, α-thiotriphosphate, β-thiophosphate, or γ-thiophosphate group, or is included in an RNA or a DNA or in an RNA analog or a DNA analog. 2. A double-stranded oligonucleotide comprising the nucleobase pair of claim 1 . 3. The nucleobase pair of claim 1 , wherein the ribosyl, deoxyribosyl, or dideoxyribosyl moiety or analog thereof is included in an RNA. 4. The nucleobase pair of claim 1 , wherein the ribosyl, deoxyribosyl, or dideoxyribosyl moiety or analog thereof is included in a DNA. 5. The nucleobase pair of claim 1 , wherein each X in structure β9b is carbon. 6. The nucleobase pair of claim 1 , wherein each R 2 in structure β9b is hydrogen. 7. The nucleobase pair of claim 1 , wherein Y is sulfur. 8. The nucleobase pair of claim 7 , wherein E in structure β9b is sulfur. 9. The nucleobase pair of claim 1 , wherein the first nucleobase analog is 10. The nucleobase pair of claim 1 , wherein the first nucleobase analog is 11. The nucleobase pair of claim 1 , wherein each X in structure α15b and α15a is carbon. 12. The nucleobase pair of claim 1 , wherein the second nucleobase analog has the structure α15b. 13. The nucleobase pair of claim 12 , wherein R 1 in structure α15b is methyl. 14. The nucleobase pair of claim 13 , wherein E in structure α15b is oxygen. 15. The nucleobase pair of claim 12 , wherein each R 2 in structure α15b is hydrogen. 16. The nucleobase pair of claim 12 , wherein the second nucleobase analog is 17. The nucleobase pair of claim 1 , wherein the second nucleobase analog has the structure α15a. 18. The nucleobase pair of claim 17 , wherein at least one R 2 is CN. 19. The nucleobase pair of claim 17 , wherein R 1 in structure α15a is methyl. 20. The nucleobase pair of claim 19 , wherein E in structure α15a is oxygen. 21. The nucleobase pair of claim 17 , wherein the second nucleobase analog is 22. The nucleobase pair of claim 1 , wherein the second nucleobase analog has any of the structures wherein each R is independently hydrogen, or the reactive linker. 23. The nucleobase pair of claim 1 , wherein the first nucleobase analog is 24. The nucleobase pair of claim 23 , wherein the second nucleobase analog is 25. The nucleobase pair of claim 1 , wherein the first nucleobase analog is and the second nucleobase analog is 26. The nucleobase pair of claim 1 , wherein the first nucleobase analog is and the second nucleobase analog is 27. The nucleobase pair of claim 1 , wherein the first nucleobase analog is and the second nucleobase analog is 28. The nucleobase pair of claim 1, 7, or 8 , wherein at least one R 2 in structure β9b is halogen. 29. The nucleobase pair of claim 8 , wherein each X in structure β9b is carbon. 30. The nucleobase pair of claim 1 , wherein the first nucleobase analog is 31. The nucleobase pair of claim 1 , wherein the first nucleobase analog is and the second nucleobase analog is 32. A nucleobase pair comprising a first nucleobase analog having the structure and a second nucleobase analog having the structure wherein the wavy line indicates a point of bonding to a ribosyl, deoxyribosyl, or dideoxyribosyl moiety, wherein the ribosyl, deoxyribosyl, or dideoxyribosyl moiety (i) has its 5′-hydroxy group in free form or bound to a mono-phosphate, diphosphate, triphosphate, α-thiotriphosphate, β-thiophosphate, γ-thiophosphate group, or (ii) is included in an RNA or a DNA. 33. A nucleobase pair comprising a first nucleobase analog having the structure and a second nucleobase analog having the structure wherein the wavy line indicates a point of bonding to a ribosyl, deoxyribosyl, or dideoxyribosyl moiety, wherein the ribosyl, deoxyribosyl, or dideoxyribosyl moiety (i) has its 5′-hydroxy group in free form or bound to a mono-phosphate, diphosphate, triphosphate, α-thiotriphosphate, β-thiophosphate, or γ-thiophosphate group, or (ii) is included in an RNA or a DNA. 34. A double-stranded oligonucleotide comprising the nucleobase pair of claim

Assignees

Inventors

Classifications

  • Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

  • In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair · CPC title

  • Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

  • with deoxyribosyl as saccharide radical · CPC title

  • Enhancement of hybridisation reaction · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12281137B2 cover?
Provided herein are analogs of unnatural nucleotides bearing predominantly hydrophobic nucleobase analogs that form unnatural base pairs during DNA polymerase-mediated replication of DNA or RNA polymerase-mediated transcription of RNA. In this manner, the unnatural nucleobases can be introduced in a site-specific way into oligonucleotides (single or double stranded DNA or RNA), where they can p…
Who is the assignee on this patent?
Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification C07H19/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).